Want to join the conversation?
$IRM said it is cooperating fully with the United Kingdom's Competition and Markets Authority (CMA) and plans to offer acceptable undertakings in order to address the CMA's concerns. As required under the Scheme Implementation Deed, $IRM will make any divestments that are required in order to obtain the approval of the CMA.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.